Literature DB >> 19681900

Renal functional outcomes for tumours in a solitary kidney managed by ablative or extirpative techniques.

Jay D Raman1, Ganesh V Raj, Steven M Lucas, Steve K Williams, Eric M Lauer, Kamran Ahrar, Surena F Matin, Raymond J Leveillee, Jeffrey A Cadeddu.   

Abstract

OBJECTIVE: To present the renal functional outcomes for patients treated with open partial nephrectomy (OPN) or radiofrequency ablation (RFA) for tumours in a solitary kidney, as renal masses in a solitary kidney present a challenging treatment dilemma. PATIENTS AND METHODS: A retrospective review of institutional databases identified 89 patients with 98 renal tumours in a solitary kidney managed by RFA or OPN under cold ischaemia between January 1997 and September 2007. The choice of therapy was based on patient and surgeon preference, tumour characteristics and comorbidities. Renal function was calculated using the modified Modification of Diet in Renal Disease equation.
RESULTS: Outcomes from 47 patients treated by RFA and 42 by OPN were analysed at a median follow-up of 18.1 and 30.0 months, respectively (P = 0.02). The median age (65.9 vs 59.6 years, P = 0.03) and American Society of Anesthesiology score (3.0 vs 2.0, P = 0.01) were both higher in patients treated with RFA. The median tumour size was greater for tumours managed by OPN (3.9 vs 2.8 cm, P = 0.001), while the median preoperative glomerular filtration rate (GFR) was lower in the RFA group (46.5 vs 55.9 mL/min/1.73 m(2) for OPN, P = 0.04). Compared to RFA, patients treated with OPN had a greater decline in GFR at all times evaluated, including soon after the procedure (15.8% vs 7.1%), 12 months after surgery (24.5% vs 10.4%) and at the last follow-up (28.6% vs 11.4%, all P < 0.001). For patients with a pretreatment GFR of > 60 or > 30 mL/min/1.73 m(2), there was a new onset of decline in GFR of <60 and <30 mL/min/1.73 m(2) in none and 7% of patients after RFA, and in 35% and 17% after OPN.
CONCLUSION: Ablative techniques, which obviate ischaemic insults, might be a particularly attractive option for managing tumours in solitary renal units at risk of declining function. Renal functional outcomes compare favourably to extirpative surgery using cold ischaemia.

Entities:  

Mesh:

Year:  2009        PMID: 19681900     DOI: 10.1111/j.1464-410X.2009.08776.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  20 in total

Review 1.  Results of radiofrequency kidney tumor ablation: renal function preservation and oncologic efficacy.

Authors:  Nelson Salas; Rajan Ramanathan; Scott Dummett; Raymond J Leveillee
Journal:  World J Urol       Date:  2010-05-09       Impact factor: 4.226

2.  Safety, efficacy and predictors of local recurrence after percutaneous radiofrequency ablation of biopsy-proven renal cell carcinoma.

Authors:  Michael Z Su; Fatima Memon; Howard M Lau; Andrew J Brooks; Manish I Patel; Henry H Woo; Simon V Bariol; Philip Vladica
Journal:  Int Urol Nephrol       Date:  2016-07-18       Impact factor: 2.370

3.  Renal function and oncologic outcomes in nephron sparing surgery for renal masses in solitary kidneys.

Authors:  Daniel J Lee; Greg Hruby; Mitchell C Benson; James M McKiernan
Journal:  World J Urol       Date:  2010-07-11       Impact factor: 4.226

Review 4.  Is robotic partial nephrectomy convenient for solitary kidney?

Authors:  Jihad H Kaouk; Ercan Malkoç
Journal:  Turk J Urol       Date:  2016-09

Review 5.  Risk of chronic kidney disease after cancer nephrectomy.

Authors:  Lin Li; Wei Ling Lau; Connie M Rhee; Kevin Harley; Csaba P Kovesdy; John J Sim; Steve Jacobsen; Anthony Chang; Jaime Landman; Kamyar Kalantar-Zadeh
Journal:  Nat Rev Nephrol       Date:  2014-01-14       Impact factor: 28.314

Review 6.  Laparoscopic and image-guided radiofrequency ablation of renal tumors: patient selection and outcomes.

Authors:  Scott M Castle; Vladislav Gorbatiy; Obi Ekwenna; Raymond J Leveillee
Journal:  Curr Urol Rep       Date:  2011-04       Impact factor: 3.092

7.  Clinical outcomes of percutaneous radiofrequency ablation for small renal cancer.

Authors:  Keiichi Ito; Shigeyoshi Soga; Kenji Seguchi; Yusuke Shinchi; Ayako Masunaga; Shinsuke Tasaki; Kenji Kuroda; Akinori Sato; Junichi Asakuma; Akio Horiguchi; Hiroshi Shinmoto; Tatsumi Kaji; Tomohiko Asano
Journal:  Oncol Lett       Date:  2017-05-26       Impact factor: 2.967

8.  Short-term functional and oncological outcomes of partial nephrectomy for renal cell carcinoma in patients with an anatomically or functionally solitary kidney: single-center experience.

Authors:  Takeshi Maehana; Toshiaki Tanaka; Hiroshi Kitamura; Naoya Masumori; Taiji Tsukamoto
Journal:  Int J Clin Oncol       Date:  2012-10-12       Impact factor: 3.402

9.  Percutaneous radiofrequency ablation of small renal tumours in patients with a single functioning kidney: long-term results.

Authors:  Miltiadis Krokidis; Stavros Spiliopoulos; Magdalena Jarzabek; Nikos Fotiadis; Tarun Sabharwal; Tim O'Brien; Andy Adam
Journal:  Eur Radiol       Date:  2013-03-09       Impact factor: 5.315

Review 10.  Ablative therapies for small renal tumours.

Authors:  Arturo Castro; Lawrence C Jenkins; Nelson Salas; Gideon Lorber; Raymond J Leveillee
Journal:  Nat Rev Urol       Date:  2013-04-23       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.